Motivational impairment in primary psychiatric and medical illness

Psychiatric Annals

Volumn 27, Issue 1, 1997, Pages 34-38

  Krupp, Brandon H ^a   Fogel, Barry S ^b  

^a Eleanor Slater Hospital   (United States)

^b BROWN UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 6944246709     PISSN: 00485713     EISSN: None     Source Type: Journal    
DOI: 10.3928/0048-5713-19970101-09     Document Type: Article

References (61)

1. Marin RS. Differential diagnosis and classification of apathy. Am J Psychiatry. 1990; 147:22-30.
2. Diagnostic and Statistical Manual of Mental Disorders. 4th ed. Washington, DC: American Psychiatric Association Press; 1995.
3. Green SA. Principles of medical psychotherapy. In: Stoudemire A, Fogel BS, eds. Psychiatric Care of the Medical Patient. New York, NY: Oxford University Press; 1993:3-18.
4. Akiskal H, Rosenthal T, Haykal R, et al. Characterological depressions: clinical and sleep EEG findings separating affective dysthymias from character spectrum disorders. Arch Gen Psychiatry. 1980; 37:777-783.
5. Blumenthal MD. Depressive illness in old age: getting behind the mask. Geriatrics. 1980; 35:34-43.
6. Marin RS. Apathy and related disorders of diminished motivation. In: Dickstein LJ, Riba MB, Oldham JM, eds. Review of Psychiatry. Vol 15. Washington, DC: American Psychiatric Association Press; 1996:205-242.
7. Floru L, Heinrich K, Wittek F. The problem of postpsychotic schizophrenic depressions and their pharmacologic induction. International Pharmacopsychiatry. 1975; 10:230-239.
8. Salloway S, Malloy P, Kohn R, et al. MRI and neuropsychological differences in early- and late-life onset geriatric depression. Neurology. 1996; 6:1571-1574.
9. Post RM. Mood disorders: somatic treatment. In: Kaplan HI, Sadock BJ, eds. Comprehensive Textbook of Psychiatry. 5th ed. Baltimore, Md: Williams & Wilkins; 1989:913.
10. Rosenbaum JF, ed. Mania: important new findings. J Clin Psychiatry. 1989; 50(suppl):2.
11. Hoehn-Saric R, Lipsey JR, McLeod DR. Apathy and indifference in patients on fluvoxamine and fluoxetine. J Clin Psychopharmacol. 1990; 10:343-345.
12. Andreason NC. Negative symptoms in schizophrenia. Arch Gen Psychiatry. 1982; 39:784-788.
13. Angrist B, Rotrosen J, Gershon S. Differential effects of neuroleptics on negative versus positive symptoms in schizophrenia. Psychopharmacology. 1980; 72:17-19.
14. Duffy JD. The neurology of alcoholic denial: implications for assessment and treatment. Can J Psychiatry. 1995; 40:257-263.
15. Swift RM. Alcohol and drug abuse in the medical setting. In: Stoudemire A, Fogel BS, eds. Psychiatric Care of the Medical Patient. New York, NY: Oxford University Press; 1993:139-153.
16. Gawin FH, Klever HD. Abstinence symptomatology and psychiatric diagnosis in cocaine abusers: clinical observations. Arch Gen Psychiatry. 1986; 46:117-121.
17. Gersten SP. Long term adverse effects of brief marijuana use. J Clin Psychiatry. 1980; 41:60-61.
18. Jaffe JH, Martin WR. Opioid analgesics and antagonists. In: Gilman AC, Goodman LS, Ral TW, et al, eds. The Pharmacological Basis of Therapeutics. 8th ed. New York, NY: Macmillan; 1990:485-521.
19. Wilson DR, Widmer RD, Cadoset RJ. Somatic symptoms: a major feature of depression in family practice. J Affect Disord. 1983; 5:199-207.
20. Lipowsky ZJ. Somatization: a borderland between medicine and psychiatry. Can Med Assoc J. 1986; 135:609-614.
21. Turk DC, Rudy TE. Toward an empirically derived taxonomy of chronic pain patients: integration of psychological assessment data. J Consult Clin Psychol. 1990; 56:233-238.
22. Cross SA. Pathophysiology of pain. Mayo Clin Proc. 1994; 69:375-383.
23. Hardy SGP. Projections to the midbrain from the medial versus lateral prefrontal cortices of the rat. Neurosci Lett. 1986; 63:159-164.
24. Berlin RM, Litovitz GL, Diaz M, et al. Sleep disorders on a psychiatric consultation service. Am J Psychiatry. 1984; 141:582-584.
25. Chikkalingaiah R, Regestein QR. Incidence of suspected sleep apnea among inpatients. Sleep Research. 1991; 20:225.
26. Critchly M. Periodic hyposomnia and megaphagia in adolescent males. Brain. 1962; 85:627-656.
27. Tepas DL, Stock CG, Maltese JW, et al. Reported sleep of shift workers: a preliminary report. Sleep Res. 1978; 7:313.
28. Regestein QR, Monk TH. Is the poor sleep of shift workers a disorder? Am J Psychiatry. 1991; 148:1487-1493.
29. Kornstein SG, Gardner DF. Endocrine disorders. In: Stoudemire A, Fogel BS, eds. Psychiatric Care of the Medical Patient. New York, NY: Oxford University Press; 1993:657.
30. Gold MS, Pearsall HR. Hypothyroidism - or is it depression? Psychosomatics. 1983; 24:646-656.
31. Thomas FB, Mazzaferri EL, Skillman TG. Apathetic thyrotoxicosis: a distinctive clinical and laboratory entity. Ann Intern Med. 1970; 72:679-685.
32. Katz IR, Beaston-Wimmer P, Parmelee P, Friedman E, Lawton P. Failure to thrive: exploration of the concept and delineation of psychiatric components. J Geriatr Psychiatry Neurol. 1993; 6:161-169.
33. Starkman MN, Schteingart DE. Neuropsychiatric manifestations of patients with Cushing's syndrome. Arch Intern Med. 1981; 141:215-219.
34. Haskett RF. Diagnostic categorization of psychiatric disturbance in Cushing's syndrome. Am J Psychiatry. 1985; 142:911-916.
35. Whelan TB, Schteingart DE, Starkman MN, et al. Neuropsychological deficits in Cushing's syndrome. J Nerv Ment Dis. 1980; 168:753-757.
36. Popkin MK, Mackenzie TB. Psychiatric presentations of endocrine dysfunction. In: Hall RCW, ed. Psychiatric Presentations of Medical Illness. New York, NY: Spectrum Publications; 1980:139-156.
37. Varadaraj R, Cooper AJ. Addison's disease presenting with psychiatric symptoms. Am J Psychiatry. 1986; 143:553-554. Letter.
38. Brown GG, Preisman RC, Kleerekoper M. Neurobehavioral symptoms in mild primary hyperparathyroidism: related to hypercalcemia but not improved by parathyroidectomy. Henry Ford Hosp Medicine. 1987; 35:211-215.
39. Joborn C, Hetta J, Rastad J, et al. Psychiatric symptoms and cerebrospinal fluid monoamine metabolites in primary hyperparathyroidism. Biol Psychiatry. 1988; 23:149-158.
40. Lustman PJ, Griffith LS, Clouse RE, et al. Psychiatric illness in diabetes mellitus: relationship to symptoms and glucose control. J Nerv Ment Dis. 1986; 174:736-742.
41. Robinson RG, Kubos KL, Starr LB, et al. Mood disorders in stroke patients: importance of location of lesion. Brain. 1984; 107:81-93.
42. Stuss DT, Benson DF. The Frontal Lobes. New York, NY: Raven Press; 1986.
43. Gordon T, Kannel WB. Premature mortality from coronary heart disease: the Framingham study. JAMA. 1971; 215:1617-1625.
44. Levenson JL. Cardiovascular disease. In: Stoudemire A, Fogel BS, eds. Psychiatric Care of the Medical Patient. New York, NY: Oxford University Press; 1993:539-563.
45. Barskey AJ, Hochstrasser B, Coles NA, et al. Silent myocardial ischemia. Is the person or the event silent? JAMA. 1990; 264:1132-1135.
46. Gabuzda DH, Hirsch MS. Neurologic manifestations of infections with human immunodeficiency virus: clinical features and pathogenesis. Ann Intern Med. 1987; 107:383-391.
47. Summergrad P, Rauch SL, Neal RR. Human immunodeficiency virus and other infectious disorders affecting the central nervous system. In: Stoudemire A, Fogel BS, eds. Psychiatric Care of the Medical Patient. New York, NY: Oxford University Press; 1993:713-737.
48. Navia BA, Jordan BD, Price RN. The AIDS-dementia complex, I: clinical features. Ann Neurol. 1986; 19:517-524.
49. Jones JF, Ray G, Minnich LL, et al. Evidence for active Epstein-Barr virus infection in patients with persistent, unexplained illnesses: elevated anti-early antigen antibodies. Ann Intern Med. 1985; 102:1-6.
50. Holmes FP, Kaplan JE, Ganz NM, et al. Chronic fatigue syndrome: a working case definition. Ann Intern Med. 1988; 108:387-389.
51. Steere AC. Lyme disease. N Engl J Med. 1989;321:586-596.
52. Fogel BS. A neuropsychiatric approach to impairment of goal-directed behavior. In: Dickstein LJ, Riba MB, Oldham JM, eds. Review of Psychiatry. Vol 15. Washington, DC: American Psychiatric Association Press; 1996:163-173.
53. Stoudemire A, Moran MG, Fogel BS. Psychotropic drug use in the medically ill, Part I. Psychosomatics. 1990; 31:377-391.
54. Stoudemire A, Moran MG, Fogel BS. Psychotropic drug use in the medically ill, Part II. Psychosomatics. 1990; 32:34-46.
55. McConnell H, Snyder P, Duffy JD, et al. Neurobehavioral toxicity of felbamate. J Neuropsychiatry Clin Neurosci. 1996; 8:341-346.
56. Seligman MEP, Abramson LY, Semmel A, von Baeyer C. Depressive attributional style. J Abnorm Psychol. 1979; 88:242-247.
57. Marin RS, Biedrzycki RC, Firinciogullari S. Reliability and validity of the Apathy Evaluation Scale. Psychiatry Res. 1991; 38:143-162.
58. Bandura A. Self-efficacy: toward a unifying theory of behavioral change. Psychol Rev. 1977; 84:191-215.
59. Rodin J. Behavioral medicine: beneficial effects of self-control training in aging. International Review of Applied Psychology. 1983; 32:153-181.
60. Coleman PD, Flood DG. Neuron number and dendritic extent in normal aging and Alzheimer's disease. Neurobiol Aging. 1987; 8:521-545.
61. Marin RS, Fogel BS, Hawkins J, Duffy J, Krupp B. Apathy: a treatable syndrome. J Neuropsychiatry Clin Neurosci. 1995; 7:23-30.